Bourne Lent Asset Management Inc. reduced its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,380 shares of the medical research company’s stock after selling 350 shares during the quarter. […]